|
Founded in 2023, LifeShare Innovations drives positive change by supporting the advancement of the research and technologies that help health care practitioners better understand diseases and how to improve outcomes for organ, eye and tissue transplantation. We partner with leaders in our profession to foster collaboration between organ procurement organizations (OPOs) and research facilities to save more lives.
|
|
|
Collaborate with us!At LifeShare Network, we are dedicated to maximizing rare organ donation opportunities by leveraging the unique experience of our colleagues and continually striving to expand our research capabilities.
If you are a collaborator with an idea or innovation that can help us improve and advance organ donation and transplant, we want to hear from you! |
CURRENT COLLABORATORS:
Revalia Bio - Research Exclusive Donation
|
LifeShare Innovations and Revalia Bio work together to advance biomedical research for individuals with end-stage, malignant lung cancer. With Oklahoma ranking 42 out of 42 nationally for lung cancer survival at 21.2%, and 20% of individuals in the state receiving no follow-up care after a lung cancer diagnosis, there is a critical need for innovative approaches to research and treatment.
As a biotech company, Revalia Bio specializes in biomedical research using human organs rather than animal models. Together, we have established a program known as RED (Research, Education, and Donation). RED provides a unique option for individuals facing terminal illness to contribute to biomedical research using their organs. The collaboration ensures donors understand their gift will not only maximize their legacy but also directly impact the future of cancer care. |
Revalia Bio -
|
|
